Test Aids Management of Breast Cancer

(Fullerton, CA, USA). CA 15-3 antigen levels are most commonly elevated in patients with breast cancer, but can also be present in patients with lung, ovarian, pancreatic, and colorectal cancer, as well as nonmalignant conditions such as benign breast and liver disease, cirrhosis, and hepatitis.

"Increased CA 15-3 antigen levels may reflect a progression of breast cancer, while decreasing levels may indicate a positive response to therapy,” said Vernon Mustoe, Ph.D., a medical information scientist at Beckman Coulter. The company's tumor marker menu also includes the recently announced Access GI Monitor for pancreatic cancer. The BR Monitor is also available on the Access 2 and UniCel DxI 800 Access immunoassay systems.




Related Links:
Beckman Coulter